Hippocampal atrophy evidenced by MRI is one of the most validated biomarkers of Alzheimer’s disease (AD). The previous neuropathological data showed a differential vulnerability of hippocampal subfields to AD processes. This study aims to use an automated analysis technique for subfield hippocampal volume measurement in order to differentiate early detection of AD. We demonstrated high diagnostic efficacy of using hippocampal subfield analysis for discriminating AD subjects from heathy control (HC) or mild cognitive impairment (MCI) than whole hippocampal volume and feasibility for discriminating MCI to HC as compared with amyloid PET result.
This abstract and the presentation materials are available to members only; a login is required.